Perfil personal
Cuantificación de educación / académica
Residency, University Of Chicago
1971
Residency, University Of Chicago
1967
Doctor of Medicine, Case Western Reserve University
1965
Experiencia relacionada con los ODS de las Naciones Unidas
En 2015, los estados miembros de las Naciones Unidas acordaron 17 Objetivos de Desarrollo Sostenible (ODS) para erradicar la pobreza, proteger el planeta y garantizar la prosperidad para todos. El trabajo de esta persona contribuye al logro de los siguientes ODS:
-
Good health and well being
Huella digital
- 1 Perfiles similares
Proyectos
- 15 Terminado
-
An Open-label Extension Phase of the Double-blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Studies to Evaluate the Efficacy and Safety of E2007(perampanel)Given as Adjunctive Therapy in Subjects with Refractory Partial Seizures
Bensalem Owen, M. (PI), Baumann, R. (CoI) & Fakhoury, T. (Former PI)
5/8/09 → 10/31/14
Proyecto: Research project
-
A Double-blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (perampanel) Given as Adjunctive Therapy in Subjects with Refractory Partial Seizures
Bensalem Owen, M. (PI), Baumann, R. (CoI) & Fakhoury, T. (Former PI)
11/1/08 → 10/31/12
Proyecto: Research project
-
Safety and Effectiveness of Open-Label clobazam in Subjects with Lennox-Gastaut Syndrome
Bensalem Owen, M. (PI), Baumann, R. (CoI), Fakhoury, T. (CoI) & Khan, G. (CoI)
7/1/08 → 3/31/09
Proyecto: Research project
-
Safety and Effectiveness of Open-Label clobazam in Subjects with Lennox-Gastaut Syndrome
Bensalem Owen, M. (PI), Baumann, R. (CoI), Khan, G. (CoI) & Fakhoury, T. (Former CoI)
7/1/08 → 3/31/13
Proyecto: Research project
-
An Open-Label, Multicenter, Follow-up Trial to Evaluate the Long-Term Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment at a Flexible Dose Up to a Maximum of 150 mg/day in Subjects Aged 16 years or Older Suffering from Epilepsy
Fakhoury, T. (PI), Baumann, R. (CoI) & Bensalem Owen, M. (CoI)
3/26/08 → 3/25/11
Proyecto: Research project
-
David Clark
Baumann, R. J. & Swick, H. M., ene 1 2021, Child Neurology: Its Origins, Founders, Growth and Evolution. p. 340-343 4 p.Producción científica: Chapter › revisión exhaustiva
-
Evaluation of two fosphenytoin loading dose regimens and monitoring in infants and neonates less than six months of age
Bohannon, K. K., Leung, N., Cook, A. M., Autry, E., Gibson, J., Naranjo, V., Baumann, R. & Gardner, B., 2020, En: Journal of Pediatric Pharmacology and Therapeutics. 25, 7, p. 617-622 6 p.Producción científica: Article › revisión exhaustiva
Acceso abierto2 Citas (Scopus) -
Continuous Intravenous Valproate as Abortive Therapy for Pediatric Status Migrainosus
Zafar, M. S., Stewart, A. M., Toupin, D. N., Cook, A. M. & Baumann, R. J., 2018, En: Neurologist. 23, 2, p. 43-46 4 p.Producción científica: Article › revisión exhaustiva
18 Citas (Scopus) -
Pharmacokinetics and Clinical Utility of Valproic Acid Administered via Continuous Infusion
Cook, A. M., Zafar, M. S., Mathias, S., Stewart, A. M., Albuja, A. C., Bensalem-Owen, M., Kapoor, S. & Baumann, R. J., ene 1 2016, En: CNS Drugs. 30, 1, p. 71-77 7 p.Producción científica: Article › revisión exhaustiva
17 Citas (Scopus) -
The place of generic modified-release formulations for epilepsy: Slow and steady
Baumann, R. J., sept 20 2016, En: Neurology. 87, 12, p. 1305-1306 2 p.Producción científica: Comment/debate